Prospective Study of Undiagnosed Celiac Disease

Completed · Not applicable

Conditions studied: Celiac Disease

In brief

Direct benefits to the participants, who are diagnosed with celiac disease may be substantial and could include lessening or prevention of GI symptoms, correction of biochemical abnormalities and reduction in risk for malignancies or bone disease which are most common in untreated celiac disease. However, the precise benefit is unknown and the motivation for this proposed study. If these individuals have a positive celiac serology test at the present time there is a high likelihood that they may have celiac disease.

Key facts

Study ID

NCT01317914

Run by

Mayo Clinic

People needed

31

Starts

2010-07-01

Expected to finish

2012-04-01

Last updated by the study team

2017-10-02

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 60 years old
• Male and female
• Retrospective testing for celiac disease was done on previously stored serum. Contacting specific individuals for inclusion into study

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.